BXP: 3Q25 Results
(BXP; Baa3/BBBneg/NR)
Beat BBG consensus and firmed up FFO/sh guidance. Occupancy doing slightly better with some strong leasing activity in major markets. Signs of recovery in CBD’s evident. Credit Neutral.
• Total revenues were $872m, better than BBG consensus of $860m and up 1.4% YOY.
• Occupancy was 86.0%. CBD occupancy stood at 89.3%. 89.2% of the total portfolio was leased.
• Said this was best quarter for leases signed (1.5m sq/ft) since pre-Covid, and up 38% over last year. Big additions in Boston, NYC and Reston, VA.
• Net income was $(116.8)m due to losses from JVs and impairment costs. Was $108.5m last year.
• Funds from Operations were $276.7m down from $286.9m last year.
• FFO/Sh of $1.74/sh was ahead of consensus of $1.72/sh
• For FY25, improved low end of range of FFO/sh - now $6.89-6.92, saw $6.84-6.92
Find more articles and bullets on these widgets:
Last week’s rally in USDCAD cancels a recent bearish theme and instead strengthens a bullish outlook. The pair has breached a key resistance at 1.3925, the May 20 high and bull trigger. The breach confirms a resumption of the bull cycle that started Jun 16. This paves the way for a climb towards 1.4019, a Fibonacci retracement point. On the downside, first key support lies at 1.3800, the 50-day EMA.
The AUDUSD uptrend remains intact and the latest pullback is considered corrective - for now. However, the pair has breached support at the 50-day EMA, at 0.6551. A clear break of this average signals scope for a deeper retracement and exposes 0.6527 (pierced), a Fibonacci retracement. For bulls, a reversal higher would refocus attention on 0.6707, the Sep 17 high. Initial firm resistance to watch is 0.6628, the Sep 24 high.
The trend set-up in EURJPY is unchanged, it remains bullish and the cross traded to a fresh cycle high last week. This confirms a resumption of the uptrend and maintains the bullish price sequence of higher highs and higher lows. Moving average studies are in a bull-mode too, highlighting a dominant uptrend. Sights are on 175.43, the Jul 11 ‘24 high and a key M/T resistance. On the downside, first support to watch lies at 173.53, the 20-day EMA.